SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 158 filers reported holding SANGAMO THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is 0.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $17,813 | -8.2% | 32,786 | +1.3% | 0.00% | – |
| Q3 2023 | $19,404 | -44.7% | 32,350 | +19.8% | 0.00% | – |
| Q2 2023 | $35,100 | -41.7% | 27,000 | -21.1% | 0.00% | – |
| Q1 2023 | $60,192 | -29.2% | 34,200 | +26.3% | 0.00% | – |
| Q4 2022 | $85,034 | -35.6% | 27,081 | +0.3% | 0.00% | – |
| Q3 2022 | $132,000 | -98.3% | 27,000 | -96.2% | 0.00% | -100.0% |
| Q2 2015 | $7,944,000 | -29.3% | 716,300 | 0.0% | 0.00% | -20.0% |
| Q1 2015 | $11,232,000 | +3.1% | 716,300 | 0.0% | 0.01% | 0.0% |
| Q4 2014 | $10,895,000 | +31.2% | 716,300 | -6.9% | 0.01% | +25.0% |
| Q3 2014 | $8,302,000 | -43.1% | 769,800 | -19.4% | 0.00% | -33.3% |
| Q2 2014 | $14,589,000 | -26.4% | 955,400 | -12.8% | 0.01% | -33.3% |
| Q1 2014 | $19,817,000 | – | 1,096,100 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alexandria Capital, LLC | 968,505 | $12,135,000 | 1.23% |
| Golden State Equity Partners | 126,608 | $1,586,000 | 0.90% |
| McGuire Investment Group, LLC | 272,801 | $3,418,000 | 0.72% |
| Lombard Odier Asset Management (Switzerland) SA | 848,429 | $10,631,000 | 0.70% |
| Rhenman & Partners Asset Management AB | 765,000 | $9,585,000 | 0.67% |
| EMC Capital Management | 72,061 | $903,000 | 0.64% |
| WASATCH ADVISORS LP | 10,328,423 | $129,415,000 | 0.58% |
| Ceeto Capital Group, LLC | 74,000 | $927,000 | 0.45% |
| Fort Sheridan Advisors LLC | 75,945 | $952,000 | 0.38% |
| Vanguard Capital Wealth Advisors | 34,580 | $388,679,000 | 0.33% |